These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31856222)

  • 1. Impact on mortality of being seropositive for hepatitis C virus antibodies among blood donors in Brazil: A twenty-year study.
    Filho HRM; Bierrenbach ALS; Capuani MLD; Mendrone A; Benzaken AS; Machado SM; Saivish MV; Sabino EC; Witkin SS; Mendes-Corrêa MC
    PLoS One; 2019; 14(12):e0226566. PubMed ID: 31856222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality among blood donors seropositive and seronegative for Chagas disease (1996-2000) in São Paulo, Brazil: A death certificate linkage study.
    Capuani L; Bierrenbach AL; Alencar AP; Mendrone A; Ferreira JE; Custer B; Ribeiro ALP; Sabino EC
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005542. PubMed ID: 28545053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival analysis over a 20-year period of a Brazilian cohort of blood donors coinfected HIV-HCV.
    de Menezes Filho HR; Grandi G; Vaz Cardoso LP; Galvão da Silva JF; Machado SM; de Almeida-Neto C; Sabino EC; Mendes-Corrêa MC
    Braz J Infect Dis; 2023; 27(5):102810. PubMed ID: 37813358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.
    Piselli P; Serraino D; Fusco M; Girardi E; Pirozzi A; Toffolutti F; Cimaglia C; Taborelli M;
    BMC Infect Dis; 2021 Jul; 21(1):667. PubMed ID: 34238231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors.
    Guiltinan AM; Kaidarova Z; Custer B; Orland J; Strollo A; Cyrus S; Busch MP; Murphy EL
    Am J Epidemiol; 2008 Mar; 167(6):743-50. PubMed ID: 18203734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality among British Columbians testing for hepatitis C antibody.
    Yu A; Spinelli JJ; Cook DA; Buxton JA; Krajden M
    BMC Public Health; 2013 Apr; 13():291. PubMed ID: 23547940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis--Brazil.
    Treitinger A; Spada C; Ferreira LA; Neto MS; Reis M; Verdi JC; de Miranda AF; de Oliveira OV; Van der Sander Silveira M; Abdalla DS
    Braz J Infect Dis; 2000 Aug; 4(4):192-6. PubMed ID: 11008223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.
    Kovari H; Rauch A; Kouyos R; Rougemont M; Cavassini M; Schmid P; Stöckle M; Bernasconi E; Weber R; Ledergerber B;
    Clin Infect Dis; 2017 Feb; 64(4):490-497. PubMed ID: 28172403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu, China.
    He Y; Zhang J; Zhong L; Chen X; Liu HM; Wan LK; Wang H; Li H; Tian L; Hu JL; Luo P; Wang L; Chen Y; Liu T; Liu SL; Lü WB
    J Med Virol; 2011 Apr; 83(4):616-21. PubMed ID: 21328375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors.
    Mandal AK; Kraus ES; Samaniego M; Rai R; Humphreys SL; Ratner LE; Maley WR; Burdick JF
    Clin Transplant; 2000 Aug; 14(4 Pt 2):391-6. PubMed ID: 10946777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India.
    Jain A; Rana SS; Chakravarty P; Gupta RK; Murthy NS; Nath MC; Gururaja S; Chaturvedi N; Verma U; Kar P
    Eur J Epidemiol; 2003; 18(7):695-7. PubMed ID: 12952145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease.
    Muñoz-Gómez R; García-Monzón C; García-Buey L; Lo Iacono O; Borque MJ; Garía-Sánchez A; Pajares JM; Moreno-Otero R
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):273-7. PubMed ID: 8724030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C infection in children who received extracorporeal membrane oxygenation.
    Nelson SP; Jonas MM
    J Pediatr Surg; 1996 May; 31(5):644-8. PubMed ID: 8861472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus RNA (HCV-RNA) in blood donors and family members seropositive for anti-HCV antibodies.
    Alvarez-Muñoz MT; Vences-Aviles MA; Damacio L; Vázquez-Rosales G; Torres J; González-Bravo F; Muñoz O
    Arch Med Res; 2001; 32(5):442-5. PubMed ID: 11578761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
    Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
    J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
    Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
    PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.